Q2 2023 · 13F-HR/A
CHI Advisors LLCholdings as filed
Filed 2023-08-22 · accession 0001085146-23-003476
$329.6M
Reported value
26
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $56.5M | 17.1% | 3,117,017 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $55.7M | 16.9% | 2,663,806 | Common | SOLE |
| H9060V101 | — | VECTIVBIO HLDG AG | $46.9M | 14.2% | 2,782,756 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $36.7M | 11.1% | 3,414,189 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $31.7M | 9.63% | 2,998,734 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $16.2M | 4.90% | 402,118 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $13.9M | 4.22% | 2,122,040 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $9.0M | 2.73% | 2,829,712 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $8.7M | 2.65% | 3,414,468 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $8.6M | 2.62% | 852,007 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $6.7M | 2.02% | 1,195,027 | Common | SOLE |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $5.9M | 1.79% | 1,055,882 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $5.6M | 1.69% | 125,139 | Common | SOLE |
| 25460G716 | LABDUSD | DIREXION SHS ETF TR | $4.7M | 1.42% | 325,000 | Common | SOLE |
| 68570P200 | — | ORCHARD THERAPEUTICS PLC | $3.9M | 1.19% | 755,738 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $3.9M | 1.19% | 85,000 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $3.8M | 1.15% | 750,000 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $3.1M | 0.93% | 542,774 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $2.8M | 0.86% | 864,822 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $2.4M | 0.73% | 767,445 | Common | SOLE |
| 74019P108 | — | PRECISION BIOSCIENCES INC | $843,471 | 0.26% | 1,603,557 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $694,091 | 0.21% | 788,740 | Common | SOLE |
| 38870X104 | GRPH | GRAPHITE BIO INC | $600,439 | 0.18% | 230,938 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $458,000 | 0.14% | 200,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $161,828 | 0.05% | 130,300 | CALL | SOLE |
| 35655L206 | — | FREELINE THERAPEUTICS HLDGS | $55,898 | 0.02% | 21,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.